1 – 10 of 198
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Efficacy and Safety of Rituximab in Antiglomerular Basement Membrane Disease
(
- Contribution to journal › Article
-
Mark
Primary glomerular diseases and long-term adverse health outcomes : A nationwide cohort study
(
- Contribution to journal › Article
-
Mark
Long-term Outcomes of Lupus Nephritis in Comparison to Other CKD Etiologies
(
- Contribution to journal › Article
-
Mark
IgA vasculitis nephritis - outcomes in adult-onset disease
(
- Contribution to journal › Article
-
Mark
In-Depth Analysis of Disease Manifestations in Antineutrophil Cytoplasmic Antibody–Associated Vasculitides Identifies Distinct Clinical Phenotypes
(
- Contribution to journal › Article
- 2024
-
Mark
EULAR recommendations for the management of ANCA-associated vasculitis : 2022 update
(
- Contribution to journal › Article
-
Mark
Epidemiology and clinical characteristics of biopsy-confirmed adult-onset IgA vasculitis in southern Sweden
(
- Contribution to journal › Article
-
Mark
Using imlifidase to elucidate the characteristics and importance of anti-GBM antibodies produced after start of treatment
2024) In Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 39(1). p.45-54(
- Contribution to journal › Article
-
Mark
Imlifidase in kidney transplantation
(
- Contribution to journal › Scientific review
-
Mark
Validation of IgA nephropathy diagnosis in the Swedish Renal Registry
(
- Contribution to journal › Article